TABLE 4.
Oral immunization with PspA-expressing Salmonella strains protects BALB/cJ mice against i.p. challenge with 3 × 103 CFU of capsular type 3 S. pneumoniae
Vaccine straina | PspA expressionb | No. of mice | % Alive on post- challenge dayc
|
Median day of deathd | |
---|---|---|---|---|---|
2 | 15 | ||||
χ4550(pYA3193) | + | 35 | 97 | 66 | >15.0** |
χ4550(pYA3148) | − | 10 | 100 | 30 | 4.0 |
None (not immunized) | NA | 10 | 80 | 0 | 3.0* |
Mice were orally immunized two times at 1-month intervals with the indicated vaccine strains.
+, PspA expressed; −, PspA not expressed; NA, not applicable.
Four weeks after the second oral immunization, mice were challenged in two experiments with approximately 3 × 103 CFU of S. pneumoniae WU2. Both experiments gave similar results, and the data from each have been pooled for presentation and analysis. The LD50 of WU2 in nonimmunized BALB/c mice was <102 (data not shown).
* and **, respectively, indicate P values of 0.009 and 0.004 versus the time to death of mice immunized with the PspA− vector pYA3148, as calculated by the two-tailed Wilcoxon two-sample rank test.